After 11 Years of Severe Hip Pain, 41-Year-Old Man from Mauritius Avoids Hip Replacement Through Cell-Based Therapy

After 11 Years of Severe Hip Pain, 41-Year-Old Man from Mauritius Avoids Hip Replacement Through Cell-Based Therapy

Navi Mumbai, Jan 23: A 41-year-old man from Mauritius, who had been living with debilitating hip pain for over 11 years due to advanced Avascular Necrosis (AVN), has successfully avoided hip replacement surgery after undergoing cell-based regenerative therapy at StemRx Hospital & Research Centre, Navi Mumbai. Treated under the care of Dr. Pradeep Mahajan, Regenerative Medicine Researcher and Founder of StemRx, the patient has experienced significant pain relief, improved mobility, and a renewed quality of life.

Mr. Kavraj Singh Bohani had been suffering from persistent pain, stiffness, and severely restricted movement for more than a decade. Over the last three to four years, his condition worsened considerably, affecting his ability to walk, sleep, work, and perform everyday activities. Multiple medical consultations in Mauritius recommended hip replacement surgery as the only viable option. Long-term use of pain medication offered only temporary relief and began impacting his mental and emotional well-being.

In search of a non-surgical, root-cause-focused solution, Mr. Bohani learned about StemRx through the Medi Check Clinic in Mauritius and decided to travel to India for treatment.

At StemRx Hospital, a comprehensive evaluation confirmed advanced AVN of the hip, a condition caused by reduced blood supply to the bone, leading to bone damage and joint degeneration. Based on the assessment, the medical team designed a personalised regenerative medicine protocol aimed at restoring blood flow, reducing inflammation, and stimulating natural bone healing.

Even before the primary therapy commenced, the patient showed improvement through supportive care and physiotherapy. He subsequently underwent stem cell-based regenerative therapy, supported by a multidisciplinary treatment approach that included targeted cell therapy, physiotherapy, quantum energy medicine, Hyperbaric Oxygen Therapy (HBOT), and EBOO (Extracorporeal Blood Oxygenation and Ozonation). The integrated strategy focused on slowing or halting disease progression, relieving pain, improving joint function, and avoiding joint replacement surgery.

Commenting on the case, Dr. Pradeep Mahajan, Regenerative Medicine Researcher & Founder, StemRx Hospital & Research Centre, said,

“Avascular necrosis develops when the blood supply to the bone is compromised, leading to progressive damage and severe pain. In many cases, joint replacement is advised as the final option. Our approach focuses on addressing the disease at the cellular level—by improving blood flow, reducing inflammation, and stimulating bone regeneration. In Mr. Bohani’s case, a customised stem cell therapy protocol helped support recovery of the hip joint and significantly improve his quality of life.”

He added,

“What stood out in this case was the patient’s determination and trust in the treatment process. With consistent therapy and rehabilitation, we observed meaningful improvements in pain levels, mobility, and overall function. This case highlights how regenerative medicine can offer hope to patients who believe surgery is their only option.”

Sharing his experience, Mr. Kavraj Singh Bohani said,

“For years, pain controlled every part of my life. I couldn’t work properly, sleep peacefully, or even step out without discomfort. Doctors told me surgery was the only way forward. Coming to StemRx changed everything. Today, I am almost pain-free and no longer dependent on medicines. I finally feel hopeful again.”

He further added,

“Dr. Mahajan gave me confidence from day one. His calm approach and clear explanations made me feel safe throughout the treatment. Before opting for a hip replacement, I would strongly encourage anyone suffering from AVN to explore regenerative therapy. It truly gave me my life back.”

This case underscores the potential of cell-based regenerative medicine in offering effective, non-surgical treatment options for chronic and debilitating conditions such as Avascular Necrosis—helping patients restore mobility, dignity, and long-term quality of life.